APA (7th ed.) Citation

Hashemian, S. M. R., Sheida, A., Taghizadieh, M., Memar, M. Y., Hamblin, M. R., Bannazadeh Baghi, H., . . . Mirzaei, H. (2023). Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy? Biomedicine & pharmacotherapy, 162, 114367. https://doi.org/10.1016/j.biopha.2023.114367

Chicago Style (17th ed.) Citation

Hashemian, Seyed Mohammad Reza, Amirhossein Sheida, Mohammad Taghizadieh, Mohammad Yousef Memar, Michael R. Hamblin, Hossein Bannazadeh Baghi, Javid Sadri Nahand, Zatollah Asemi, and Hamed Mirzaei. "Paxlovid (Nirmatrelvir/Ritonavir): A New Approach to Covid-19 Therapy?" Biomedicine & Pharmacotherapy 162 (2023): 114367. https://doi.org/10.1016/j.biopha.2023.114367.

MLA (9th ed.) Citation

Hashemian, Seyed Mohammad Reza, et al. "Paxlovid (Nirmatrelvir/Ritonavir): A New Approach to Covid-19 Therapy?" Biomedicine & Pharmacotherapy, vol. 162, 2023, p. 114367, https://doi.org/10.1016/j.biopha.2023.114367.